Table of Content



1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Varicella Attenuated Live Vaccine
1.2 Key Market Segments
1.2.1 Varicella Attenuated Live Vaccine Segment by Type
1.2.2 Varicella Attenuated Live Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats

2 Varicella Attenuated Live Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Varicella Attenuated Live Vaccine Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Varicella Attenuated Live Vaccine Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 Varicella Attenuated Live Vaccine Market Competitive Landscape
3.1 Global Varicella Attenuated Live Vaccine Sales by Manufacturers (2017-2022)
3.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.3 Varicella Attenuated Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Varicella Attenuated Live Vaccine Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Varicella Attenuated Live Vaccine Sales Sites, Area Served, Product Type
3.6 Varicella Attenuated Live Vaccine Market Competitive Situation and Trends
3.6.1 Varicella Attenuated Live Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Varicella Attenuated Live Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion

4 Varicella Attenuated Live Vaccine Industry Chain Analysis
4.1 Varicella Attenuated Live Vaccine Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 The Development and Dynamics of Varicella Attenuated Live Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 Varicella Attenuated Live Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Varicella Attenuated Live Vaccine Sales Market Share by Type (2017-2022)
6.3 Global Varicella Attenuated Live Vaccine Market Size Market Share by Type (2017-2022)
6.4 Global Varicella Attenuated Live Vaccine Price by Type (2017-2022)

7 Varicella Attenuated Live Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Varicella Attenuated Live Vaccine Market Sales by Application (2017-2022)
7.3 Global Varicella Attenuated Live Vaccine Market Size (M USD) by Application (2017-2022)
7.4 Global Varicella Attenuated Live Vaccine Sales Growth Rate by Application (2017-2022)

8 Varicella Attenuated Live Vaccine Market Segmentation by Region
8.1 Global Varicella Attenuated Live Vaccine Sales by Region
8.1.1 Global Varicella Attenuated Live Vaccine Sales by Region
8.1.2 Global Varicella Attenuated Live Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Varicella Attenuated Live Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Varicella Attenuated Live Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Varicella Attenuated Live Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Varicella Attenuated Live Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Varicella Attenuated Live Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa

9 Key Companies Profiled
9.1 Merck
9.1.1 Merck Varicella Attenuated Live Vaccine Basic Information
9.1.2 Merck Varicella Attenuated Live Vaccine Product Overview
9.1.3 Merck Varicella Attenuated Live Vaccine Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Varicella Attenuated Live Vaccine SWOT Analysis
9.1.6 Merck Recent Developments
9.2 BCHT
9.2.1 BCHT Varicella Attenuated Live Vaccine Basic Information
9.2.2 BCHT Varicella Attenuated Live Vaccine Product Overview
9.2.3 BCHT Varicella Attenuated Live Vaccine Product Market Performance
9.2.4 BCHT Business Overview
9.2.5 BCHT Varicella Attenuated Live Vaccine SWOT Analysis
9.2.6 BCHT Recent Developments
9.3 Shanghai Institute
9.3.1 Shanghai Institute Varicella Attenuated Live Vaccine Basic Information
9.3.2 Shanghai Institute Varicella Attenuated Live Vaccine Product Overview
9.3.3 Shanghai Institute Varicella Attenuated Live Vaccine Product Market Performance
9.3.4 Shanghai Institute Business Overview
9.3.5 Shanghai Institute Varicella Attenuated Live Vaccine SWOT Analysis
9.3.6 Shanghai Institute Recent Developments
9.4 GSK
9.4.1 GSK Varicella Attenuated Live Vaccine Basic Information
9.4.2 GSK Varicella Attenuated Live Vaccine Product Overview
9.4.3 GSK Varicella Attenuated Live Vaccine Product Market Performance
9.4.4 GSK Business Overview
9.4.5 GSK Varicella Attenuated Live Vaccine SWOT Analysis
9.4.6 GSK Recent Developments
9.5 Keygen
9.5.1 Keygen Varicella Attenuated Live Vaccine Basic Information
9.5.2 Keygen Varicella Attenuated Live Vaccine Product Overview
9.5.3 Keygen Varicella Attenuated Live Vaccine Product Market Performance
9.5.4 Keygen Business Overview
9.5.5 Keygen Varicella Attenuated Live Vaccine SWOT Analysis
9.5.6 Keygen Recent Developments
9.6 Green Cross
9.6.1 Green Cross Varicella Attenuated Live Vaccine Basic Information
9.6.2 Green Cross Varicella Attenuated Live Vaccine Product Overview
9.6.3 Green Cross Varicella Attenuated Live Vaccine Product Market Performance
9.6.4 Green Cross Business Overview
9.6.5 Green Cross Recent Developments
9.7 Biken
9.7.1 Biken Varicella Attenuated Live Vaccine Basic Information
9.7.2 Biken Varicella Attenuated Live Vaccine Product Overview
9.7.3 Biken Varicella Attenuated Live Vaccine Product Market Performance
9.7.4 Biken Business Overview
9.7.5 Biken Recent Developments
9.8 Shanghai Rongsheng Biotech
9.8.1 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Basic Information
9.8.2 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Product Overview
9.8.3 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Product Market Performance
9.8.4 Shanghai Rongsheng Biotech Business Overview
9.8.5 Shanghai Rongsheng Biotech Recent Developments
9.9 Changchun Changsheng Life Sciences Limited
9.9.1 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Basic Information
9.9.2 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Product Overview
9.9.3 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Product Market Performance
9.9.4 Changchun Changsheng Life Sciences Limited Business Overview
9.9.5 Changchun Changsheng Life Sciences Limited Recent Developments
10 Varicella Attenuated Live Vaccine Market Forecast by Region
10.1 Global Varicella Attenuated Live Vaccine Market Size Forecast
10.2 Global Varicella Attenuated Live Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Varicella Attenuated Live Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Varicella Attenuated Live Vaccine Market Size Forecast by Region
10.2.4 South America Varicella Attenuated Live Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Varicella Attenuated Live Vaccine by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Varicella Attenuated Live Vaccine Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Varicella Attenuated Live Vaccine by Type (2022-2028)
11.1.2 Global Varicella Attenuated Live Vaccine Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Varicella Attenuated Live Vaccine by Type (2022-2028)
11.2 Global Varicella Attenuated Live Vaccine Market Forecast by Application (2022-2028)
11.2.1 Global Varicella Attenuated Live Vaccine Sales (K Units) Forecast by Application
11.2.2 Global Varicella Attenuated Live Vaccine Market Size (M USD) Forecast by Application (2022-2028)

12 Conclusion and Key Findings



List of Figures

?LIST OF TABLES

Table 1. Introduction of the Type

Table 2. Introduction of the Application

Table 3. Market Size (M USD) Segment Executive Summary

Table 4. Varicella Attenuated Live Vaccine Market Size (M USD) Comparison by Region (M USD)

Table 5. Global Varicella Attenuated Live Vaccine Sales (K Units) by Manufacturers (2017-2022)

Table 6. Global Varicella Attenuated Live Vaccine Sales Market Share by Manufacturers (2017-2022)

Table 7. Global Varicella Attenuated Live Vaccine Revenue (M USD) by Manufacturers (2017-2022)

Table 8. Global Varicella Attenuated Live Vaccine Revenue Share by Manufacturers (2017-2022)

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Varicella Attenuated Live Vaccine as of 2021)

Table 10. Global Market Varicella Attenuated Live Vaccine Average Price (USD/Unit) of Key Manufacturers (2017-2022)

Table 11. Manufacturers Varicella Attenuated Live Vaccine Sales Sites and Area Served

Table 12. Manufacturers Varicella Attenuated Live Vaccine Product Type

Table 13. Global Varicella Attenuated Live Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion Plans

Table 15. Industry Chain Map of Varicella Attenuated Live Vaccine

Table 16. Raw Materials

Table 17. Midstream Market Analysis

Table 18. Downstream Customer Analysis

Table 19. Key Development Trends

Table 20. Driving Factors

Table 21. Varicella Attenuated Live Vaccine Market Challenges

Table 22. Market Restraints

Table 23. Global Varicella Attenuated Live Vaccine Sales by Type (K Units)

Table 24. Global Varicella Attenuated Live Vaccine Market Size by Type (M USD)

Table 25. Global Varicella Attenuated Live Vaccine Sales (K Units) by Type (2017-2022)

Table 26. Global Varicella Attenuated Live Vaccine Sales Market Share by Type (2017-2022)

Table 27. Global Varicella Attenuated Live Vaccine Market Size (M USD) by Type (2017-2022)

Table 28. Global Varicella Attenuated Live Vaccine Market Size Share by Type (2017-2022)

Table 29. Global Varicella Attenuated Live Vaccine Price (USD/Unit) by Type (2017-2022)

Table 30. Global Varicella Attenuated Live Vaccine Sales (K Units) by Application

Table 31. Global Varicella Attenuated Live Vaccine Market Size by Application

Table 32. Global Varicella Attenuated Live Vaccine Sales by Application (2017-2022) & (K Units)

Table 33. Global Varicella Attenuated Live Vaccine Sales Market Share by Application (2017-2022)

Table 34. Global Varicella Attenuated Live Vaccine Sales by Application (2017-2022) & (M USD)

Table 35. Global Varicella Attenuated Live Vaccine Market Share by Application (2017-2022)

Table 36. Global Varicella Attenuated Live Vaccine Sales Growth Rate by Application (2017-2022)

Table 37. Global Varicella Attenuated Live Vaccine Sales by Region (2017-2022) & (K Units)

Table 38. Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2017-2022)

Table 39. North America Varicella Attenuated Live Vaccine Sales by Country (2017-2022) & (K Units)

Table 40. Europe Varicella Attenuated Live Vaccine Sales by Country (2017-2022) & (K Units)

Table 41. Asia Pacific Varicella Attenuated Live Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. South America Varicella Attenuated Live Vaccine Sales by Country (2017-2022) & (K Units)

Table 43. Middle East and Africa Varicella Attenuated Live Vaccine Sales by Region (2017-2022) & (K Units)

Table 44. Merck Varicella Attenuated Live Vaccine Basic Information

Table 45. Merck Varicella Attenuated Live Vaccine Product Overview

Table 46. Merck Varicella Attenuated Live Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 47. Merck Business Overview

Table 48. Merck Varicella Attenuated Live Vaccine SWOT Analysis

Table 49. Merck Recent Developments

Table 50. BCHT Varicella Attenuated Live Vaccine Basic Information

Table 51. BCHT Varicella Attenuated Live Vaccine Product Overview

Table 52. BCHT Varicella Attenuated Live Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 53. BCHT Business Overview

Table 54. BCHT Varicella Attenuated Live Vaccine SWOT Analysis

Table 55. BCHT Recent Developments

Table 56. Shanghai Institute Varicella Attenuated Live Vaccine Basic Information

Table 57. Shanghai Institute Varicella Attenuated Live Vaccine Product Overview

Table 58. Shanghai Institute Varicella Attenuated Live Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 59. Shanghai Institute Business Overview

Table 60. Shanghai Institute Varicella Attenuated Live Vaccine SWOT Analysis

Table 61. Shanghai Institute Recent Developments

Table 62. GSK Varicella Attenuated Live Vaccine Basic Information

Table 63. GSK Varicella Attenuated Live Vaccine Product Overview

Table 64. GSK Varicella Attenuated Live Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 65. GSK Business Overview

Table 66. GSK Varicella Attenuated Live Vaccine SWOT Analysis

Table 67. GSK Recent Developments

Table 68. Keygen Varicella Attenuated Live Vaccine Basic Information

Table 69. Keygen Varicella Attenuated Live Vaccine Product Overview

Table 70. Keygen Varicella Attenuated Live Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 71. Keygen Business Overview

Table 72. Keygen Varicella Attenuated Live Vaccine SWOT Analysis

Table 73. Keygen Recent Developments

Table 74. Green Cross Varicella Attenuated Live Vaccine Basic Information

Table 75. Green Cross Varicella Attenuated Live Vaccine Product Overview

Table 76. Green Cross Varicella Attenuated Live Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 77. Green Cross Business Overview

Table 78. Green Cross Recent Developments

Table 79. Biken Varicella Attenuated Live Vaccine Basic Information

Table 80. Biken Varicella Attenuated Live Vaccine Product Overview

Table 81. Biken Varicella Attenuated Live Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 82. Biken Business Overview

Table 83. Biken Recent Developments

Table 84. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Basic Information

Table 85. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Product Overview

Table 86. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 87. Shanghai Rongsheng Biotech Business Overview

Table 88. Shanghai Rongsheng Biotech Recent Developments

Table 89. Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Basic Information

Table 90. Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Product Overview

Table 91. Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 92. Changchun Changsheng Life Sciences Limited Business Overview

Table 93. Changchun Changsheng Life Sciences Limited Recent Developments

Table 94. Global Varicella Attenuated Live Vaccine Sales Forecast by Region (K Units)

Table 95. Global Varicella Attenuated Live Vaccine Market Size Forecast by Region (M USD)

Table 96. North America Varicella Attenuated Live Vaccine Sales Forecast by Country (2022-2028) & (K Units)

Table 97. North America Varicella Attenuated Live Vaccine Market Size Forecast by Country (2022-2028) & (M USD)

Table 98. Europe Varicella Attenuated Live Vaccine Sales Forecast by Country (2022-2028) & (K Units)

Table 99. Europe Varicella Attenuated Live Vaccine Market Size Forecast by Country (2022-2028) & (M USD)

Table 100. Asia Pacific Varicella Attenuated Live Vaccine Sales Forecast by Region (2022-2028) & (K Units)

Table 101. Asia Pacific Varicella Attenuated Live Vaccine Market Size Forecast by Region (2022-2028) & (M USD)

Table 102. South America Varicella Attenuated Live Vaccine Sales Forecast by Country (2022-2028) & (K Units)

Table 103. South America Varicella Attenuated Live Vaccine Market Size Forecast by Country (2022-2028) & (M USD)

Table 104. Middle East and Africa Varicella Attenuated Live Vaccine Consumption Forecast by Country (2022-2028) & (Units)

Table 105. Middle East and Africa Varicella Attenuated Live Vaccine Market Size Forecast by Country (2022-2028) & (M USD)

Table 106. Global Varicella Attenuated Live Vaccine Sales Forecast by Type (2022-2028) & (K Units)

Table 107. Global Varicella Attenuated Live Vaccine Market Size Forecast by Type (2022-2028) & (M USD)

Table 108. Global Varicella Attenuated Live Vaccine Price Forecast by Type (2022-2028) & (USD/Unit)

Table 109. Global Varicella Attenuated Live Vaccine Sales (K Units) Forecast by Application (2022-2028)

Table 110. Global Varicella Attenuated Live Vaccine Market Size Forecast by Application (2022-2028) & (M USD)

List of Figures

Figure 1. Product Picture of Varicella Attenuated Live Vaccine

Figure 2. Data Triangulation

Figure 3. Key Caveats

Figure 4. Global Varicella Attenuated Live Vaccine Market Size (M USD), 2017-2028

Figure 5. Global Varicella Attenuated Live Vaccine Market Size (M USD) (2017-2028)

Figure 6. Global Varicella Attenuated Live Vaccine Sales (K Units) & (2017-2028)

Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 9. Evaluation Matrix of Regional Market Development Potential

Figure 10. Varicella Attenuated Live Vaccine Market Size (M USD) by Country (M USD)

Figure 11. Varicella Attenuated Live Vaccine Sales Share by Manufacturers in 2020

Figure 12. Global Varicella Attenuated Live Vaccine Revenue Share by Manufacturers in 2020

Figure 13. Varicella Attenuated Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 14. Global Market Varicella Attenuated Live Vaccine Average Price (USD/Unit) of Key Manufacturers in 2020

Figure 15. The Global 5 and 10 Largest Players: Market Share by Varicella Attenuated Live Vaccine Revenue in 2021

Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 17. Global Varicella Attenuated Live Vaccine Market Share by Type

Figure 18. Sales Market Share of Varicella Attenuated Live Vaccine by Type (2017-2022)

Figure 19. Sales Market Share of Varicella Attenuated Live Vaccine by Type in 2021

Figure 20. Market Size Share of Varicella Attenuated Live Vaccine by Type (2017-2022)

Figure 21. Market Size Market Share of Varicella Attenuated Live Vaccine by Type in 2020

Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 23. Global Varicella Attenuated Live Vaccine Market Share by Application

Figure 24. Global Varicella Attenuated Live Vaccine Sales Market Share by Application (2017-2022)

Figure 25. Global Varicella Attenuated Live Vaccine Sales Market Share by Application in 2021

Figure 26. Global Varicella Attenuated Live Vaccine Market Share by Application (2017-2022)

Figure 27. Global Varicella Attenuated Live Vaccine Market Share by Application in 2020

Figure 28. Global Varicella Attenuated Live Vaccine Sales Growth Rate by Application (2017-2022)

Figure 29. Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2017-2022)

Figure 30. North America Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 31. North America Varicella Attenuated Live Vaccine Sales Market Share by Country in 2020

Figure 32. U.S. Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 33. Canada Varicella Attenuated Live Vaccine Sales (K Units) and Growth Rate (2017-2022)

Figure 34. Mexico Varicella Attenuated Live Vaccine Sales (Units) and Growth Rate (2017-2022)

Figure 35. Europe Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 36. Europe Varicella Attenuated Live Vaccine Sales Market Share by Country in 2020

Figure 37. Germany Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 38. France Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 39. U.K. Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 40. Italy Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 41. Russia Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 42. Asia Pacific Varicella Attenuated Live Vaccine Sales and Growth Rate (K Units)

Figure 43. Asia Pacific Varicella Attenuated Live Vaccine Sales Market Share by Region in 2020

Figure 44. China Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 45. Japan Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 46. South Korea Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 47. India Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 48. Southeast Asia Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 49. South America Varicella Attenuated Live Vaccine Sales and Growth Rate (K Units)

Figure 50. South America Varicella Attenuated Live Vaccine Sales Market Share by Country in 2020

Figure 51. Brazil Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 52. Argentina Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 53. Columbia Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 54. Middle East and Africa Varicella Attenuated Live Vaccine Sales and Growth Rate (K Units)

Figure 55. Middle East and Africa Varicella Attenuated Live Vaccine Sales Market Share by Region in 2020

Figure 56. Saudi Arabia Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 57. UAE Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 58. Egypt Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 59. Nigeria Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 60. South Africa Varicella Attenuated Live Vaccine Sales and Growth Rate (2017-2022) & (K Units)

Figure 61. Global Varicella Attenuated Live Vaccine Sales Forecast by Volume (2017-2028) & (K Units)

Figure 62. Global Varicella Attenuated Live Vaccine Market Size Forecast by Value (2017-2028) & (M USD)

Figure 63. Global Varicella Attenuated Live Vaccine Sales Market Share Forecast by Type (2022-2028)

Figure 64. Global Varicella Attenuated Live Vaccine Market Share Forecast by Type (2022-2028)

Figure 65. Global Varicella Attenuated Live Vaccine Sales Forecast by Application (2022-2028)

Figure 66. Global Varicella Attenuated Live Vaccine Market Share Forecast by Application (2022-2028)